Jim Stallard, MA

Senior Writer/Editor

Recent Blog Posts

Pictured: Robin Roberts & Tonya Samuel
In the News
Wednesday, February 20, 2013

Co-host Robin Roberts gives thanks to her Memorial Sloan Kettering treatment team during her first day returning to the show after receiving a stem cell transplant.

Pictured: Neurons
In the Lab
Monday, February 11, 2013

Researchers have clarified the process by which developing nerve cells are directed to specialize into distinct parts.

Pictured: CancerSmart Lecture
Video
Tuesday, February 5, 2013

In a recent discussion as part of Memorial Sloan Kettering’s CancerSmart lecture series, bladder cancer experts spoke about symptoms, risk factors, and the latest treatment options available.

Pictured: BCG
In the Lab
Friday, February 1, 2013

Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.

Pictured: Mark Bilsky
In the O.R.
Friday, January 25, 2013

Our doctors have shown that tumors compressing the spinal cord can be controlled using less-invasive surgery combined with a precise, intense form of radiation therapy.

Pictured: Marcel R. M. van den Brink
In the Clinic
Friday, December 21, 2012

Memorial Sloan Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.

Pictured: Marc Ladanyi & Snjezana Dogan
In the Clinic
Friday, November 9, 2012

A genetic analysis of tumors suggests women are more susceptible than men to the most common form of lung cancer.

Pictured: Martin Weiser
In the Clinic
Thursday, November 8, 2012

Memorial Sloan Kettering’s colorectal cancer team has developed online prediction tools that assess disease risk following surgery, enabling patients and physicians to make better treatment decisions.

Feature
Monday, September 24, 2012

Dr. Gany works to identify the causes of health disparities in underserved communities, and to develop ways to more effectively deliver care to ethnically diverse populations.

Cancer Care
Feature
Friday, September 21, 2012

With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.

Pictured: Ross Levine
In the Lab
Thursday, September 6, 2012

Memorial Sloan Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.

Pictured: Kenneth Offit & Zsofia Stadler
In the Lab
Friday, August 17, 2012

Memorial Sloan Kettering investigators have found that some testicular cancers arising early in life may result from genetic changes that have not been inherited from either parent.

Pictured: Nadeem R. Abu-Rustum
In the O.R.
Monday, July 9, 2012

Memorial Sloan Kettering surgeons have pioneered a technique that may improve quality of life for women with early-stage gynecologic cancers.

Pictured: Ross Levine
In the Lab
Thursday, March 15, 2012

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

Pictured: David Panicek & Barbara Raphael
Feature
Thursday, March 1, 2012

Memorial Sloan Kettering trains medical students, residents, and fellows to become leaders in cancer diagnosis and treatment.